Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Devi

Showing results (341-350 of 382) with videos related to

Pageof 39
Sort By:
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1987
Immunological studies in asthmatics exposed to allergensM Maheshwari, M Jaju, P S Devi, et al.
Phytotherapy Research : PTR|May 2, 2007
Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental ratsR S Devi, Shoba Narayan, G Vani, et al.
Oncogene|October 5, 2019
EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathwayHanwen Zhang, Dan Zhu, Zhaobin Zhang, et al.
Human Biology|August 1, 1989
Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of IndiaD Labie, R Srinivas, O Dunda, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 18, 2003
A baseline survey of the prevalence of tuberculosis in a community in south India at the commencement of a DOTS programmeP G Gopi, R Subramani, S Radhakrishna, et al.
International Journal of Immunopathology and Pharmacology|March 6, 2004
T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumorsD Kempuraj, R S Devi, B Madhappan, et al.
Zeitschrift Fur Morphologie Und Anthropologie|December 1, 1993
Genetic serum protein markers in eight south Indian caste and tribal populationsH Walter, J M Naidu, H Danker-Hopfe, et al.
Oncogene|November 3, 2019
Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathwayHanwen Zhang, Dan Zhu, Zhaobin Zhang, et al.
Journal of Cardiovascular Disease Research|December 13, 2012
Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patientsB K Manjunatha Goud, Bhavna Nayal, Oinam S Devi, et al.
Bioscience Reports|March 29, 2022
Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological studySandra Jose, Sreevidya S Devi, Anjana Sajeev, et al.
Pageof 39

Showing results (341-350 of 382) with videos related to

Sort By:
Pageof 39
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1987
Immunological studies in asthmatics exposed to allergensM Maheshwari, M Jaju, P S Devi, et al.
Phytotherapy Research : PTR|May 2, 2007
Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental ratsR S Devi, Shoba Narayan, G Vani, et al.
Oncogene|October 5, 2019
EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathwayHanwen Zhang, Dan Zhu, Zhaobin Zhang, et al.
Human Biology|August 1, 1989
Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of IndiaD Labie, R Srinivas, O Dunda, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 18, 2003
A baseline survey of the prevalence of tuberculosis in a community in south India at the commencement of a DOTS programmeP G Gopi, R Subramani, S Radhakrishna, et al.
International Journal of Immunopathology and Pharmacology|March 6, 2004
T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumorsD Kempuraj, R S Devi, B Madhappan, et al.
Zeitschrift Fur Morphologie Und Anthropologie|December 1, 1993
Genetic serum protein markers in eight south Indian caste and tribal populationsH Walter, J M Naidu, H Danker-Hopfe, et al.
Oncogene|November 3, 2019
Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathwayHanwen Zhang, Dan Zhu, Zhaobin Zhang, et al.
Journal of Cardiovascular Disease Research|December 13, 2012
Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patientsB K Manjunatha Goud, Bhavna Nayal, Oinam S Devi, et al.
Bioscience Reports|March 29, 2022
Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological studySandra Jose, Sreevidya S Devi, Anjana Sajeev, et al.
Pageof 39